Therapeutic Class
Astellas eyes AMD cell therapy trial restart after manufacturing tweaks
Therapeutic ClassAstellas eyes AMD cell therapy trial restart after manufacturing tweaksAstellas eyes AMD cell therapy trial restart after manufacturing tweaks
Astellas is set to restart trials for its AMD program ASP7317 after improving production efficiency and analytical process.